Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

JAMA - Journal of the American Medical Association - Tập 291 Số 16 - Trang 1963 - 2004
Mihai Gheorghiade1, Wendy A. Gattis2, Christopher M. O'Connor2, Kirkwood F. Adams3, Uri Elkayam4, Alejandro Barbagelata5, Jalal K. Ghali6, Raymond L. Benza7, Frank McGrew8, Marc Klapholz9, John Ouyang10, Cesare Orlandi10
1The University of Chicago,
2Duke University
3University of North Carolina at Chapel Hill
4University of Southern California
5Hospital Italiano de Buenos Aires
6Cardiac Centers of Louisiana
7University of Alabama
8Stem Cardiovascular Center
9Saint Vincent Catholic Medical Centers
10Otsuka Pharmaceutical Co., Ltd

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA - Journal of the American Medical Association

Tập 291 Số 16

1963

Thông tin tác giả